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Abstract
Cellular senescence is a molecular hallmark of ageing that is associated with multiple pathologies, and DNA damage marker
γH2AX, together with cell cycle inhibitor p21, have been used as senescence markers in multiple species including dogs.
Idiopathic canine chronic hepatitis has recognised breed-related differences in predisposition and prognosis, but reasons behind
this are poorly understood. This retrospective study using archived post mortem tissue aimed to provide insight into liver ageing
in 51 microscopically normal canine livers across seven breed categories, including those with and without increased risk of
chronic hepatitis. Immunohistochemistry was conducted for γH2AX, p21, and cell proliferation marker Ki67, and the mean
number of positive hepatocytes per high power field was determined. All three markers were strongly correlated to each other, but
no age-dependent expression was seen in the combined study population. Overall expression levels were low in most dogs, with
median values representing less than 1.5% of hepatocytes, but this increased to 20–30% in individual dogs at the upper end of the
range. Individual breed differences were noted in two breeds that have increased risk of chronic hepatitis, with English Springer
Spaniels having lower expression of Ki67 than other dogs, and Labradors having higher expression of Ki67 and γH2AX than
other dogs. These results warrant further investigation in these breeds and highlight a need to validate reliable markers of cellular
senescence in dogs.
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Introduction
The concept of healthy ageing and longevity is an increasing
focus in veterinary and human medicine (Kaeberlein et al.
2016). Chronological age is the single greatest risk factor for
human disease worldwide, and clustering of spontaneous age-
related chronic diseases within individuals is recognised in
both humans and animals (Gilmore and Greer 2015;
Kirkland et al. 2017). Among the nine interlinked molecular
hallmarks of mammalian ageing is cellular senescence: a state
of irreversible cell cycle arrest induced either through replica-
tive exhaustion or through a variety of cellular stresses, but in
contrast to cellular quiescence, metabolic activity is retained
and a range of inflammatory mediators are released as part of
the senescence-associated secretory phenotype (SASP)
(Lopez-Otin et al. 2013). In the short term this serves to pre-
vent propagation of injured cells with their subsequent clear-
ance by the immune system, but persistence and accumulation
of senescent cells is associated with multiple age-related pa-
thologies, and as such, induced apoptosis of senescent cells in
mice extends healthy lifespan (Baker et al. 2016).
A difficulty in studying cellular senescence is the lack of
definitive markers, in part reflecting the complex and hetero-
geneous nature of senescence in different physiological set-
tings (Munoz-Espin and Serrano 2014). The histochemical
stain for senescence-associated β-galactosidase activity
(SA-β-gal) has been a mainstay of in vitro experiments, but
cannot be visualised in formalin fixed tissue that constitutes
the majority of retrospective samples in veterinary research. In
both human fibroblasts and mouse hepatocytes, DNA damage
marker γH2AX is the best surrogate marker for SA-β-gal
(Passos et al. 2007; Wang et al. 2009). Expression of
γH2AX and cell cycle inhibitor p21 have also recently been
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used to investigate the role of senescence in the canine eye and
testes (Merz et al. 2019a, b), while increased expression of
p21 and γH2AX contributes to the senescence signature of
in vitro human hepatocytes (Aravinthan et al. 2013), making
these valid markers to explore.
Senescence, as defined by γH2AX expression, is reported
to increase with age in mouse hepatocytes (Wang et al. 2009),
and accumulation of these cells has prognostic significance in
human liver diseases, with molecular mechanisms now being
elucidated (Aravinthan and Alexander 2016). A previous
study by our group reveals a similar increase in hepatocyte
p21 expression in dogs with idiopathic chronic hepatitis
(Kortum et al. 2018), and while breed-related differences in
prevalence and prognosis are recognised (Bexfield et al.
2012), the aetiology, pathogenesis, and progression of this
disease remains poorly understood.
We hypothesised that hepatocyte senescence may increase
with age in the canine liver, and differential rates of liver
ageing may give an insight into breed predisposition
for idiopathic chronic hepatitis. In this retrospective
study, we have characterised the expression of Ki67,
γH2AX, and p21 during natural ageing in 51 micro-
scopically normal canine livers, from seven breed cate-
gories, including those with and without a recognised
increased risk of chronic hepatitis.
Materials and methods
Case selection
The pathology service database was searched for all dogs
undergoing post mortem examination between January 2006
and October 2018, with no reported liver pathology. Dogs
were recruited in seven different breed categories with the
aim of spanning the widest possible size and age range.
Three dogs had been included as controls in the previous
hepatitis study (Kortum et al. 2018). Haematoxylin and eosin
(H&E) stained sections of liver were assessed by LH under the
supervision of FCC to ensure that only microscopically nor-
mal tissues were included. Samples were considered eligible if
they had minimal autolysis, and no evidence of lesions includ-
ing necrosis, inflammation, fibrosis, oedema, haemorrhage,
hepatocyte or biliary hyperplasia, or neoplasia. Hepatic stel-
late cells were required to be < 10% relative to hepatocytes,
and cases of macrovesicular steatosis were excluded. The age,
breed, sex, and cause of death were recorded from the post
mortem report.
Histology
Sections of paraffin-embedded tissues were cut at 4 µm thick-
ness and mounted on adhesive glass slides. Serial sections
were stained using routine histological methods for H&E
and rhodanine copper staining.
Immunohistochemistry
Dewaxing, rehydration, and antigen retrieval was performed
using a combined 3-in-1 Dako PT link module (Dako), and
immunohistochemistry was performed manually by LH.
Endogenous peroxidase activity was inhibited using
EnVision FLEX Peroxidase-Blocking Reagent (Agilent
Dako) for 60 minutes. Primary antibodies were incubated for
one hour at room temperature: Ki67 at 1:400 (mouse mono-
clonal anti-Ki67, clone MIB-1, Cat no. M7240, Agilent
Dako); γH2AX at 1:1000 (mouse monoclonal anti-gamma
H2AX (phospho-S139) antibody, clone 9F3, Cat no.
Ab26350, Abcam); and p21 at 1:100 (mouse monoclonal an-
ti-p21, clone SX118, Cat no. M7202, Agilent Dako). For
samples incubated with p21 antibody, an additional step in-
volving 15 minutes incubation with EnVision FLEX mouse
linker (Agilent Dako) was found to be optimal. An HRP-
conjugated secondary antibody was applied for 30 minutes
at room temperature (Dako EnVision FLEX/HRP, Agilent
Dako), followed by incubation for five minutes with 3,3’-di-
aminobenzidine chromogen (Agilent Dako) and counterstain
with Mayer’s haematoxylin for five minutes. Sections of ca-
nine skin were used as a positive control for each antibody (for
example, as in (Kortum et al. 2018)), and negative control
slides were prepared using commercial species-matched im-
munoglobulins (Agilent Dako).
Assessment and scoring of sections
Histological scoring for rhodanine copper staining was con-
ducted by LH and reviewed by FCC, according to (Shih et al.
2007). Hepatocyte swelling and vacuolation was noted from
H&E sections and assigned a grade depending on the percent-
age of hepatocytes affected, with grade 1 = < 10%, grade 2 =
10–40%; grade 3 = 41–70%; grade 4 = > 70%.
For immunohistochemical scoring, digital images were
taken of eight random high power fields (covering 310 µm x
220 µm at 400x magnification) per marker. Scoring was con-
ducted by LH in independent triplicate, with average scores
per image recorded. LH was blinded to the breed and age of
dog and each high power field (hpf) image was scored for the
number of hepatocytes showing nuclear expression of the giv-
en marker. Hepatocytes were identified based on their polyg-
onal shape, round central nucleus, and arrangement in hepatic
cords. Hepatocytes with brown-stained nuclei were consid-
ered positive, irrespective of staining intensity (Fig. 1) and
as conducted in (Kortum et al. 2018), but these were also
subjectively assigned to either strong or weak staining inten-
sity categories with full dataset provided in the electronic sup-
plementary material. Using total numbers of positive
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hepatocytes from eight hpf, a mean number per hpf was cal-
culated for each marker in each dog.
Statistical analysis
Graphical illustrations and statistical analyses were performed
using GraphPad Prism version 8.00 for Windows (GraphPad
Software). All data were non-parametric and significance was
determined using two-tailed tests, with P values < 0.05 con-
sidered statistically significant. Correlation between variables
was assessed using Spearman correlation coefficients.
Comparisons between all breed groups were performed using
a Kruskal-Wallis test, or for ESS/Labradors compared to other
breeds using the Mann-Whitney U test.
Results
Study population
Archived samples of microscopically normal livers from 51
dogs were included in the study (Table 1 and electronic
supplementary material), with ages ranging from four months
to 18 years, and representing seven different breed categories:
10 small breeds; nine English Springer Spaniels (ESS), six
English Cocker Spaniels (ECS), 10 Cavalier King Charles
Spaniels (CKCS), five Staffordshire Bull Terriers (SBT), sev-
en Labradors, and four other large breed dogs. These catego-
ries were chosen to encompass small, medium, and large
breed dogs, as body size influences the absolute rate of ageing,
and smaller body size is associated with a longer life expec-
tancy (Kraus et al. 2013). SBT were chosen as a breed with
reduced relative risk of chronic hepatitis, while ESS, ECS, and
Labradors have increased relative risk of chronic hepatitis in
the UK population (Bexfield et al. 2012). Furthermore, ESS
typically present in young to middle age with a severe chronic
hepatitis (Bexfield et al. 2011), while Labradors generally
present in middle to older age with a slower disease progres-
sion (Shih et al. 2007).
Expression patterns of Ki67, γH2AX, and p21
in the combined study population
Immunohistochemistry was conducted using antibodies pre-
viously published in canine tissues: Ki67 as a marker of pro-
liferating cells (Fonseca-Alves et al. 2017), γH2AX as a
DNA damage marker and protein upregulated early in
the senescence pathway, and p21 as a cell cycle inhibitor and
protein activated downstream in the senescence cascade
(Merz et al. 2019a, b).
Each high power field covered an area of 310 µm x
220 µm, and contained 150–200 hepatocytes. Ki67 staining
(Fig. 1a) was observed in a random pattern of individual he-
patocytes and variable staining intensity, with median 0 (range
0-16.25) positive hepatocyte per hpf.γH2AXwas also seen in
a random pattern, predominantly with weak staining intensity,
and with median 0.625 (range 0–42) positive hepatocytes per





Fig. 1 Sample high power field
images showing expression of
Ki67, γH2AX, and p21. Image
panels illustrate expression of
Ki67 (a), γH2AX (b), and p21 (c)
with black arrows indicating cells
as examples of different positive
immunostaining intensities. All
scale bars represent 40 µm
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Table 1 Data for each of the 51 dogs with histologically normal livers
Breed Age (years) Mean Ki67 per hpfa Mean γH2AX per hpfa Mean p21 per hpfa
Yorkshire terrier 0.25 0.5 18.25 28.375
Yorkshire terrier 1.5 0 5 3.75
Dachshund 2.5 0 0.125 0
JRT 3 0 0.5 0.25
WHWT 6.5 0 0 0
Yorkshire terrier 7 0.125 0.25 0.375
JRT 11.5 0 0.375 0.125
Lakeland terrier 12 5.75 10 11.625
Yorkshire terrier 13.5 0.125 0.375 1.375
Yorkshire terrier 18 0 0 0
ESS 0.25 1 0.375 26.75
ESS 1.4 0 1.125 0.125
ESS 1.6 0 4.875 0
ESS 3 0 0.75 11.75
ESS 3.5 0 0 0.125
ESS 6 0 0 8.125
ESS 7.75 0 0.125 2.75
ESS 9 0 0 0.375
ESS 9.2 0 0 43.625
ECS 0.5 0 0.75 9.25
ECS 4.5 0 0.125 5.875
ECS 5 0.125 0 0.125
ECS 5.5 16.25 1.375 1.625
ECS 11 0.125 8.375 0.875
ECS 13.75 0 0 1.125
CKCS 1 0 0.25 0.625
CKCS 4 0 0 0
CKCS 3.5 0 5.75 0.25
CKCS 7.25 0 0.625 15.75
CKCS 9 0 14.875 0.625
CKCS 9.2 5.5 38.625 17.5
CKCS 11.5 0.375 0.25 8.625
CKCS 12 0.375 0.25 0
CKCS 12.25 0.125 10.5 59.25
CKCS 14 1.5 42.5 16.5
SBT 2.5 0.125 1.875 1.75
SBT 4 0 1.875 2.75
SBT 6.76 0 3.75 0.375
SBT 8.5 9.25 0 16.25
SBT 12 0.25 0 2.25
Labrador 1 1.875 35.875 38.125
Labrador 2 0.625 13 12.625
Labrador 3.5 0.5 1.125 21.125
Labrador 6 1 0.875 2.125
Labrador 10.5 7 10.125 8.5
Labrador 11 1.25 4.75 26.125
Labrador 15 0 2.875 0.125
Boxer 0.25 4 3.125 6
Boxer 3 0.25 0 0.25
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distribution with variable staining intensity, and median 2.19
(range 0–59) positive hepatocytes per hpf (Fig. 1c). These
median values represented less than 1.5% of hepatocytes pres-
ent, but in dogs with the highest expression levels of γH2AX
and p21, this represented around 20–30% of hepatocytes.
Within the combined study population of 51 dogs, Ki67,
γH2AX, and p21 were strongly correlated with each other
(Fig. 2a-c). Spearman correlation coefficients were as follows:
Ki67 and γH2AX, r = 0.3637, P = 0.0087; Ki67 and p21, r =
0.5042, P = 0.0002; γH2AX and p21, r = 0.3783, P = 0.0068.
Expression of Ki67, γH2AX, and p21
was not age-dependent in the combined study
population
In contrast to the correlation between markers, there was no
correlation between age and expression of Ki67, γH2AX, or
p21 in the combined study group (Fig. 2d-f). Similarly, there
was no correlation with hepatocyte vacuolation or rhodanine
staining score (Electronic supplementarymaterial), suggesting
that these were not confounding factors, but we cannot ex-
clude the possibility in this small sample size and in the ab-
sence of biochemical analysis of liver function.
Expression of Ki67, γH2AX, and p21
was not significantly different between the seven
breed groups
Figure 3 illustrates the data for the seven different breed cat-
egories, and Kruskal-Wallis comparison between all breed
groups revealed no statistically significant differences in age,
Ki67, γH2AX, or p21. Labradors had the highest median
values of all three markers, indicating that breed-related trends
may be present, but the small sample size within each group
limited statistical power in this study.
ESS and CKCS showed age-related changes in γH2AX
and Ki67 respectively
Age-dependence of marker expression was analysed within
each breed group and identified a negative correlation be-
tween γH2AX and age in ESS (Fig. 4a; r=-0.7485; P =
0.0218), while CKCS showed a positive correlation between
Ki67 and age (Fig. 4b; r = 0.7655; P = 0.0148). No other sig-
nificant correlations were seen.
ESS had lower expression of Ki67 than all other dogs
Considering individual breeds, ESS had the lowest interquar-
tile range (IQR) and lowest maximum value for Ki67
(Fig. 3b). Data from the nine ESS dogs were compared to
the other 42 dogs using the Mann-Whitney U test. ESS had
significantly lower expression of Ki67 than all other dogs
(Fig. 4c; P = 0.0218), and while there was a trend to reduced
expression of γH2AX (Fig. 4d), this did not reach statistical
significance (P = 0.0621).
Labradors had higher expression of Ki67 and γH2AX
than all other dogs
Similarly, Labrador-specific differences were detected when
data from the seven Labradors were compared to the other 44
dogs. Labradors had higher expression of Ki67 (Fig. 4f; P =
0.0132) and γH2AX (Fig. 4g; P = 0.0144), but no significant
difference in p21 compared to other dogs (Fig. 4h).
Discussion
In this study, we have examined hepatocyte expression of
Ki67, γH2AX, and p21 in microscopically normal canine
livers. In the combined study population of 51 dogs, all three
markers were strongly correlated with each other but not with
age. Overall expression levels were low in the majority of
dogs, consistent with levels reported in the normal canine
testes and eye (Merz et al. 2019a, b), and individual breed
differences were noted for ESS and Labradors.
We explored the expression of γH2AX and p21 as previ-
ously published indicators of cellular senescence in a range of
species (Aravinthan et al. 2013; Kortum et al. 2018; Merz
et al. 2019a; Wang et al. 2009), and we additionally included
Ki67 as a marker of hepatocyte proliferation. Whilst most
normal hepatocytes are in a state of replicative quiescence,
hepatocyte turnover, and therefore Ki67 expression, may be
stimulated as a result of liver injury (Delhaye et al. 1996).
Scoring was conducted irrespective of staining intensity as
this could be influenced by the oscillating expression with cell
cycle phase in the case of Ki67 (Sobecki et al. 2017), the stage
of DNA repair in the case of γH2AX (Mah et al. 2010), or
simply due to differences in original sample processing given
the retrospective nature of the project. There are no
Table 1 (continued)
Breed Age (years) Mean Ki67 per hpfa Mean γH2AX per hpfa Mean p21 per hpfa
German shepherd 9 1.375 0.375 6.25
Boxer 10.75 0 0.375 0.375
aMean number of positive hepatocytes per hpf, scored over 8 hpf. See main text for methods
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standardised methods of IHC scoring and we considered it
important to include all labelled cells including those
with weak expression, as discussed in (Fedchenko and
Reifenrath 2014).
The strong correlation between expression of Ki67,
γH2AX, and p21 reported here may reflect a common mech-
anistic link, for example in response to hepatocyte injury, with
individual hepatocytes undergoing a range of cellular re-
sponses such as proliferation, or repair of DNA damage and
cell cycle inhibition. Additionally, increased hepatocyte pro-
liferation may in turn lead to replicative senescence through
telomere erosion (Lopez-Otin et al. 2013), but the low number
of Ki67 positive cells in this study may be more consistent
with the former explanation.
We hypothesised that markers associated with cellular se-
nescence would increase with age in the canine liver. An age-
dependent increase in hepatocyte p21 expression is
documented in 15 control dog livers (Kortum et al. 2018),
and a similar age related increase in γH2AX-positive hepato-
cytes is reported in mouse liver (Wang et al. 2009). γH2AX
has not previously been investigated in the canine liver, but we
found no correlation between age and any of the markers in
our combined study population of 51 dogs. The discrepancy
with the previously published p21 study in canine liver may
be due to the different study populations, both in terms of size
(51 dogs versus 15 dogs) and breed composition, combined
with the low overall p21 immuno-positivity in the normal
canine liver. Our data indicate that senescent hepatocytes
may not accumulate with age in the canine liver. A similar
conclusion has recently been proposed in the canine eye
(Merz et al. 2019a), and examination of hepatocyte telomere
length as an indicator of replicative senescence in normal hu-
man livers reveals no age-dependent changes (Verma et al.
2012). However, our results may alternatively reflect the
a b
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Fig. 2 Ki67, γH2AX, and p21
were strongly correlated to each
other but had no age-
dependence. Positive correlations
were seen between all three
markers with Spearman
correlation coefficient r and
significance value P shown on the
respective graph: (a) Ki67 and
γH2AX, (b) Ki67 and p21, (c)
γH2AX and p21. In contrast there
was no correlation between age
and Ki67 (d), γH2AX (e), or p21
(f) in the combined study
population of 51 dogs
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biological complexity of senescence in different physiological
settings, and the lack of sensitive and specific markers. For
example, whilst we found that Ki67, γH2AX, and p21 were
strongly correlated with each other in the group as a whole,
individual discordant results for γH2AX and p21 were seen in
six dogs, and random versus peri-portal distribution may sug-
gest that these two markers have independent functional sig-
nificance. Dual label immuno-staining would be useful
to investigate concurrent expression of γH2AX and p21
by individual cells (supportive of cellular senescence)
but was unfortunately not feasible with these two pri-
mary mouse antibodies. More work is therefore needed
to validate sensitive and specific senescence markers for
canine tissues; an in vitro approach comparing candi-
dates with telomere markers and SA-β-gal may provide
further insight, but at present, care must be taken in
interpretation of results.
Our second hypothesis was that breed-related differences
in liver ageing may contribute to breed predispositions in id-
iopathic chronic hepatitis. For example, ESS typically present
at a younger age and suffer a severe form of chronic hepatitis
(Bexfield et al. 2011), while Labradors present in middle to
older age with a more slowly progressive disease (Shih et al.
2007). ESS were found to have a lower expression of Ki67
than other dogs, and in contrast to that seen for the whole
study population, γH2AX expression in ESS decreased with
advancing age. One explanation for this is that as the dogs in
the current study were selected to have no liver pathology,
those reaching older ages may have achieved “healthy age-
ing”, while younger dogs may have subsequently developed
liver disease had they not died of other causes. The odds ratio
of ESS developing chronic hepatitis is 9.4 (Bexfield et al.
2012), and in a study of 68 cases the median age at presenta-
tion is three years seven months, ranging up to eight years five
months (Bexfield et al. 2011). Five of our nine ESS were aged
over three and a half with two aged over nine years. Taken as a
breed irrespective of age, the lower Ki67 scores may suggest a
reduced regenerative response in the ESS liver, and as such
these dogs could bemore prone to destructive pathology in the











































































































































































comparisons of all seven breed
groups showed no significant
differences in age, Ki67, γH2AX,
or p21. Box and whiskers plots
with median, interquartile range
and min-max values for each
breed group to compare age dis-
tribution (a), or expression of
Ki67 (b), γH2AX (c), and p21 (d)
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In contrast, increased expression of Ki67 and γH2AX was
seen in the seven Labradors compared to other dogs, suggest-
ing both increased hepatocyte proliferation and DNA damage
in this breed. This may reflect behavioural factors such as
increased scavenging associated with increased appetite
(Raffan et al. 2016), and this may create a low grade intermit-
tent toxic liver injury similar to alcoholic liver disease in
humans. In converse to ESS, Labradors may have a robust
reparative response to liver injury, and we could speculate that
this may contribute to the later onset and slower progression of
disease. These theories are interesting but remain unproven in
this study, and it will be important for future studies to explore
these possibilities with larger cohorts of dogs.
Themain limitations of this studywere the small sample size
within each breed group, and the use of archived tissue
collected from post mortem examinations. This presented po-
tential differences in post mortem interval to sample collection,
and in subsequent tissue processing. Additionally, while all
samples were microscopically normal, there was a risk of sam-
pling error with focal liver disease, and there was no biochem-
ical information on liver function or other clinical history avail-
able for these dogs. None-the-less, this type of retrospective
study provides important insights with non-invasive experi-
mental methods.
Conclusions
This retrospective histology-based study of natural ageing in
the canine liver has revealed no age-dependent expression of
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Fig. 4 ESS, CKCS, and
Labradors showed breed-specific
trends in marker
expression. Within breeds, ESS
had a negative correlation be-
tween γH2AX and age (a), while
CKCS had a positive correlation
between Ki67 and age (b);
Spearman correlation coefficient r
and significance value P included
on the respective graphs. ESS had
significantly lower expression of
Ki67 than all other breeds com-
bined [P = 0.0218] (c) using the
Mann-Whitney U test, but no
significant difference in γH2AX
(d) or p21 (e). Labradors had
higher expression of Ki67 [P =
0.0132] (f), and γH2AX [P =
0.0144] (g), but not p21 (h) when
compared to all other breeds using
the
Mann-Whitney U test
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Ki67, γH2AX, or p21 in the group as a whole, and overall
expression levels were low. However, breed-related patterns
of Ki67 and γH2AX in ESS and Labradors warrant further
investigation with respect to predisposition to chronic hepati-
tis in these breeds. Finally, our data suggest that further work
is necessary to validate reliable markers of cellular senescence
in dogs.
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